מאמרים עם הרשאות לגישה ציבורית - Samuel Mokלמידע נוסף
לא זמינים באתר כלשהו: 5
RUNX3 protein is overexpressed in human epithelial ovarian cancer
NS Nevadunsky, JS Barbieri, J Kwong, MA Merritt, WR Welch, ...
Gynecologic oncology 112 (2), 325-330, 2009
הרשאות: US National Institutes of Health
Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms
B Litkouhi, B Litkouhi, E Fleming, WR Welch, RS Berkowitz, MJ Birrer, ...
Gynecologic oncology 109 (2), 234-239, 2008
הרשאות: US National Institutes of Health
An image informatics pipeline for imaging mass cytometry to characterize the immune landscape in pre-and on-treatment immune therapy and its application in recurrent platinium …
Y Zhu, TL Yeung, J Sheng, EM Hinchcliff, JK Burks, AA Jazaeri, SC Mok, ...
2019 IEEE EMBS International Conference on Biomedical & Health Informatics …, 2019
הרשאות: US National Institutes of Health
Identification of Biomarkers for Clear Cell Ovarian Adenocarcinoma
SC Mok, MP Stanley, H Tsuda, MJ Birrer
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal …, 2010
הרשאות: US National Institutes of Health
Inhibition of Dab2 expression with antisense oligodeoxynucleotides in mouse embryos
KK Cheung, SC Mok, H Zhao, P Rezaie, WY Chan
Neuroembryology and Aging 5 (3), 89-99, 2008
הרשאות: US National Institutes of Health
זמינים באתר כלשהו: 78
Dicer, Drosha, and outcomes in patients with ovarian cancer
WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, ...
New England Journal of Medicine 359 (25), 2641-2650, 2008
הרשאות: US National Institutes of Health
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
CL Au Yeung, NN Co, T Tsuruga, TL Yeung, SY Kwan, CS Leung, Y Li, ...
Nature communications 7 (1), 11150, 2016
הרשאות: US National Institutes of Health
TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment
TL Yeung, CS Leung, KK Wong, G Samimi, MS Thompson, J Liu, TM Zaid, ...
Cancer research 73 (16), 5016-5028, 2013
הרשאות: US National Institutes of Health
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
TL Yeung, CS Leung, KP Yip, CL Au Yeung, STC Wong, SC Mok
American Journal of Physiology-Cell Physiology 309 (7), C444-C456, 2015
הרשאות: US National Institutes of Health
Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth
L Yang, A Achreja, TL Yeung, LS Mangala, D Jiang, C Han, J Baddour, ...
Cell metabolism 24 (5), 685-700, 2016
הרשאות: US National Institutes of Health
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
SC Mok, T Bonome, V Vathipadiekal, A Bell, ME Johnson, DC Park, ...
Cancer cell 16 (6), 521-532, 2009
הרשאות: US National Institutes of Health
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
KK Wong, YTM Tsang, MT Deavers, SC Mok, Z Zu, C Sun, A Malpica, ...
The American journal of pathology 177 (4), 1611-1617, 2010
הרשאות: US National Institutes of Health
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women
TKH Chung, TH Cheung, NY Huen, KWY Wong, KWK Lo, SF Yim, ...
International journal of cancer 124 (6), 1358-1365, 2009
הרשאות: US National Institutes of Health
Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer
IG Schauer, AK Sood, S Mok, J Liu
Neoplasia 13 (5), 393-405, 2011
הרשאות: US National Institutes of Health
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer
MJ Callahan, Z Nagymanyoki, T Bonome, ME Johnson, B Litkouhi, ...
Clinical Cancer Research 14 (23), 7667-7673, 2008
הרשאות: US National Institutes of Health
Up-regulation of stromal versican expression in advanced stage serous ovarian cancer
S Ghosh, L Albitar, R LeBaron, WR Welch, G Samimi, MJ Birrer, ...
Gynecologic oncology 119 (1), 114-120, 2010
הרשאות: US National Institutes of Health
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low‐grade serous carcinoma
YT Tsang, MT Deavers, CC Sun, SY Kwan, E Kuo, A Malpica, SC Mok, ...
The Journal of pathology 231 (4), 449-456, 2013
הרשאות: US National Institutes of Health
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
CS Leung, TL Yeung, KP Yip, KK Wong, SY Ho, LS Mangala, AK Sood, ...
The Journal of clinical investigation 128 (2), 589-606, 2018
הרשאות: US Department of Defense, US National Institutes of Health
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential
CS Leung, TL Yeung, KP Yip, S Pradeep, L Balasubramanian, J Liu, ...
Nature communications 5 (1), 5092, 2014
הרשאות: US National Institutes of Health
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance
A Nowicka, FC Marini, TN Solley, PB Elizondo, Y Zhang, HJ Sharp, ...
PloS one 8 (12), e81859, 2013
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב